A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors
A repeat kidney transplant is the preferred treatment for graft failure due to its enhanced survival benefits and improved quality of life, despite facing greater medical, immunological, and surgical challenges compared to the first transplant. Immunosuppressive medications are indispensable for org...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Indian Journal of Transplantation |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijot.ijot_15_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841556823370366976 |
|---|---|
| author | Puneet Arora Rajan Duggal Deepak Garg Tarique Naseem |
| author_facet | Puneet Arora Rajan Duggal Deepak Garg Tarique Naseem |
| author_sort | Puneet Arora |
| collection | DOAJ |
| description | A repeat kidney transplant is the preferred treatment for graft failure due to its enhanced survival benefits and improved quality of life, despite facing greater medical, immunological, and surgical challenges compared to the first transplant. Immunosuppressive medications are indispensable for organ recipients to prevent rejection and prolong the viability of transplanted organs. At present, triple-drug therapy comprising calcineurin inhibitors, corticosteroids, and antiproliferative medications is the prevailing protocol for immunosuppressive treatment in renal transplant recipients. In conjunction with the intended therapeutic outcomes, the administration of immunosuppressive agents entails the potential for specific adverse reactions. This patient developed chronic diarrhea due to mycophenolate mofetil, severe bone marrow suppression with azathioprine due to thiopurine methyltransferase enzyme deficiency, and developed thrombotic microangiopathy with tacrolimus, despite maintaining recommended therapeutic drug levels, leading to the withdrawal of all three drugs. The case highlights the need for newer immunosuppressive drugs and protocols that are more effective and less toxic. |
| format | Article |
| id | doaj-art-cda1a49f19d34e6bb2ded103075f0c34 |
| institution | Kabale University |
| issn | 2212-0017 2212-0025 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Transplantation |
| spelling | doaj-art-cda1a49f19d34e6bb2ded103075f0c342025-01-07T06:12:53ZengWolters Kluwer Medknow PublicationsIndian Journal of Transplantation2212-00172212-00252024-12-0118446546810.4103/ijot.ijot_15_24A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin InhibitorsPuneet AroraRajan DuggalDeepak GargTarique NaseemA repeat kidney transplant is the preferred treatment for graft failure due to its enhanced survival benefits and improved quality of life, despite facing greater medical, immunological, and surgical challenges compared to the first transplant. Immunosuppressive medications are indispensable for organ recipients to prevent rejection and prolong the viability of transplanted organs. At present, triple-drug therapy comprising calcineurin inhibitors, corticosteroids, and antiproliferative medications is the prevailing protocol for immunosuppressive treatment in renal transplant recipients. In conjunction with the intended therapeutic outcomes, the administration of immunosuppressive agents entails the potential for specific adverse reactions. This patient developed chronic diarrhea due to mycophenolate mofetil, severe bone marrow suppression with azathioprine due to thiopurine methyltransferase enzyme deficiency, and developed thrombotic microangiopathy with tacrolimus, despite maintaining recommended therapeutic drug levels, leading to the withdrawal of all three drugs. The case highlights the need for newer immunosuppressive drugs and protocols that are more effective and less toxic.https://journals.lww.com/10.4103/ijot.ijot_15_24azathioprinecase reportcyclosporineimmunosuppressionmycophenolate mofetilrepeat kidney transplantationtacrolimus |
| spellingShingle | Puneet Arora Rajan Duggal Deepak Garg Tarique Naseem A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors Indian Journal of Transplantation azathioprine case report cyclosporine immunosuppression mycophenolate mofetil repeat kidney transplantation tacrolimus |
| title | A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors |
| title_full | A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors |
| title_fullStr | A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors |
| title_full_unstemmed | A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors |
| title_short | A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors |
| title_sort | case of repeat kidney transplant intolerant to multiple first line immunosuppressive agents mycophenolate mofetil azathioprine and calcineurin inhibitors |
| topic | azathioprine case report cyclosporine immunosuppression mycophenolate mofetil repeat kidney transplantation tacrolimus |
| url | https://journals.lww.com/10.4103/ijot.ijot_15_24 |
| work_keys_str_mv | AT puneetarora acaseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT rajanduggal acaseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT deepakgarg acaseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT tariquenaseem acaseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT puneetarora caseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT rajanduggal caseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT deepakgarg caseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors AT tariquenaseem caseofrepeatkidneytransplantintoleranttomultiplefirstlineimmunosuppressiveagentsmycophenolatemofetilazathioprineandcalcineurininhibitors |